Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lung function trajectories in patients with idiopathic pulmonary fibrosis.
Neely ML, Hellkamp AS, Bender S, Todd JL, Liesching T, Luckhardt TR, Oldham JM, Raj R, White ES, Palmer SM. Neely ML, et al. Among authors: liesching t. Respir Res. 2023 Aug 24;24(1):209. doi: 10.1186/s12931-023-02503-5. Respir Res. 2023. PMID: 37612608 Free PMC article.
Hospitalizations in patients with idiopathic pulmonary fibrosis.
Kim HJ, Snyder LD, Adegunsoye A, Neely ML, Bender S, White ES, Conoscenti CS, Strek ME; IPF-PRO Registry Investigators. Kim HJ, et al. Respir Res. 2021 Sep 30;22(1):257. doi: 10.1186/s12931-021-01851-4. Respir Res. 2021. PMID: 34592998 Free PMC article.
Disparities in Lung Transplant among Patients with Idiopathic Pulmonary Fibrosis: An Analysis of the IPF-PRO Registry.
Swaminathan AC, Hellkamp AS, Neely ML, Bender S, Paoletti L, White ES, Palmer SM, Whelan TPM, Dilling DF; Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry investigators. Swaminathan AC, et al. Ann Am Thorac Soc. 2022 Jun;19(6):981-990. doi: 10.1513/AnnalsATS.202105-589OC. Ann Am Thorac Soc. 2022. PMID: 35073248 Free PMC article.
Effect of Antifibrotic Therapy on Survival in Patients With Idiopathic Pulmonary Fibrosis.
de Andrade JA, Neely ML, Hellkamp AS, Culver DA, Kim HJ, Liesching T, Lobo LJ, Ramaswamy M, Safdar Z, Bender S, Conoscenti CS, Leonard TB, Palmer SM, Snyder LD; IPF-PRO Registry investigators. de Andrade JA, et al. Among authors: liesching t. Clin Ther. 2023 Apr;45(4):306-315. doi: 10.1016/j.clinthera.2023.03.003. Epub 2023 Mar 28. Clin Ther. 2023. PMID: 36997445 Free article.
Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort.
Todd JL, Vinisko R, Liu Y, Neely ML, Overton R, Flaherty KR, Noth I, Newby LK, Lasky JA, Olman MA, Hesslinger C, Leonard TB, Palmer SM, Belperio JA; IPF-PRO Registry investigators. Todd JL, et al. BMC Pulm Med. 2020 Mar 14;20(1):64. doi: 10.1186/s12890-020-1103-4. BMC Pulm Med. 2020. PMID: 32171287 Free PMC article.
Interstitial lung abnormalities in a large clinical lung cancer screening cohort: association with mortality and ILD diagnosis.
Patel AS, Miller E, Regis SM, Hunninghake GM, Price LL, Gawlik M, McKee AB, Rieger-Christ KM, Pinto-Plata V, Liesching TN, Wald C, Hashim J, McKee BJ, Gazourian L. Patel AS, et al. Among authors: liesching tn. Respir Res. 2023 Feb 14;24(1):49. doi: 10.1186/s12931-023-02359-9. Respir Res. 2023. PMID: 36782326 Free PMC article. Clinical Trial.
Qualitative emphysema and risk of COPD hospitalization in a multicenter CT lung cancer screening cohort study.
Gazourian L, Thedinger WB, Regis SM, Pagura EJ, Price LL, Gawlik M, Stefanescu CF, Lamb C, Rieger-Christ KM, Singh H, Casasola M, Walker AR, Rupal A, Patel AS, Come CE, Sanayei AM, Long WP, Rizzo GS, McKee AB, Washko GR, San Jose Estepar R, Wald C, McKee BJ, Thomson CC, Liesching TN. Gazourian L, et al. Among authors: liesching tn. Respir Med. 2021 Jan;176:106245. doi: 10.1016/j.rmed.2020.106245. Epub 2020 Nov 20. Respir Med. 2021. PMID: 33253972 Free PMC article.
31 results